Skip to main content
. 2018 Mar 14;7(4):335–358. doi: 10.1159/000487407

Fig. 3.

Fig. 3

Comparison of OS rates among the BCLC-A, SLHCC, and BCLC-B groups stratified by ALBI grade and treatment modality. a ALBI grade 1. b ALBI grade 2. c ALBI grade 3. d Curative treatment. e TACE. f Other treatments. ALBI, albumin-bilirubin; BCLC, Barcelona Clinic Liver Cancer; OS, overall survival; SLHCC, single large hepatocellular carcinoma; TACE, transarterial chemoembolization.